Inhalation Sciences: Corfind interviews CEO Manoush Masarrat on an eventful 2020
(Stockholm Jan 8, 2020) Inhalation Sciences (ISAB) today publishes a video interview with CEO Manoush Masarrat on ISAB’s progress in 2019 and the year ahead.In the film, Manoush Masarrat describes ISAB’s broad and growing customer base, its unique in vitro simulation tool DissolvIt, which the company expects to launch in Q1 2020, and its current clinical trials for PreciseInhale. The film is available HERE.